FDA Pilots AI-Enabled Clinical Trial Optimization — Could Cut Trial Timelines 20-40%

r/singularity·high signal

The FDA launched a first-of-its-kind pilot program using causal AI and cloud computing to monitor clinical trial data in real-time, with FDA Chief AI Officer Jeremy Walsh stating it could reduce '20, 30, 40% of overall clinical trial time.' The Federal Register RFI (published April 29) invites industry input on AI-enabled optimization of early-phase trials. The program explores automated data quality assessment, synthetic-control generation for causal inference, and AI-informed go/no-go decisions.